Page last updated: 2024-08-16

resveratrol and cytidine

resveratrol has been researched along with cytidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernhaus, A; Erker, T; Fritzer-Szekeres, M; Graser, G; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Jaschke, M; Krupitza, G; Lackner, A; Madlener, S; Ozsvar-Kozma, M; Saiko, P; Szekeres, T	1

Other Studies

1 other study(ies) available for resveratrol and cytidine

Article	Year
N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine. International journal of oncology, 2007, Volume: 31, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cytarabine; Cytidine; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes	2007

Article

Year

N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.

International journal of oncology, 2007, Volume: 31, Issue:5

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cytarabine; Cytidine; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes

2007